ArcticZymes Technologies — Director's Dealing 2017

Oct 24, 2017

Mandatory notification of trade

Mandatory notification of trade

(Tromsø 24. October 2017) Christian Jørgensen, CEO of Biotec Pharmacon has on 23

October 2017 purchased 62.000 shares in Biotec Pharmacon at NOK 8.07 per share.

After this transaction holds Mr. Jørgensen 62.000 shares in Biotec Pharmacon

This information is subject to the disclosure requirements pursuant to section 5

-12 of the Norwegian Securities Trading Act.

For further information, please contact

Børge Sørvoll

CFO

+47 952 90 187

borge.sorvoll@biotec.no